The IPO market is set to close out 2021 with a thud after Immix Biopharma, a biotech, dropped nearly 27% below its offer price. Immix (ticker: IMMX) is the third company this week to trade below its ...
Source LinkThe IPO market is set to close out 2021 with a thud after Immix Biopharma, a biotech, dropped nearly 27% below its offer price. Immix (ticker: IMMX) is the third company this week to trade below its ...
Source Link
Comments